Feedback

X
Advanced Blood-Brain Barrier Drug Delivery

Advanced Blood-Brain Barrier Drug Delivery

0 Ungluers have Faved this Work
Advanced Blood-Brain Barrier Drug Delivery is a reprint with a summary editorial, followed by 16 chapters that cover five areas of brain drug delivery, including receptor-mediated transport (RMT), carrier-mediated transport (CMT), active efflux transport (AET), Trojan horse lipid nanoparticles (LNP), and in vivo methods for measurement of drug transport across the blood–brain barrier (BBB).

This book is included in DOAB.

Why read this book? Have your say.

You must be logged in to comment.

Rights Information

Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.

Downloads

This work has been downloaded 24 times via unglue.it ebook links.
  1. 24 - pdf (CC BY) at Unglue.it.

Keywords

  • 6-OHDA
  • agonist antibody
  • alpha-synuclein (αSYN)
  • Alzheimer’s disease
  • amyotrophic lateral sclerosis (ALS)
  • antibody
  • ATP-binding cassette transporters
  • BBB–peptide shuttle
  • bispecific antibody
  • Blood-Brain Barrier
  • blood-brain barrier (BBB)
  • blood–brain barrier
  • blood–brain barrier (BBB)
  • brain delivery
  • brain drug delivery
  • carrier-mediated transport
  • cavernous sinus
  • cell toxicity
  • chaperonin-containing TCP-1
  • choline transporter-like protein-1 (CTL1)
  • compartmental models
  • decoy receptors
  • Drug delivery
  • endosomal
  • Endothelium
  • enzyme replacement therapy
  • fusion proteins
  • Genetic engineering
  • hCMEC/D3 cells
  • IGF1R
  • IgG fusion proteins
  • Immunotherapy
  • insulin receptor
  • ischemic stroke
  • large amino acid transporter 1 (LAT1)
  • lipid nanoparticle
  • Liposome
  • liposomes
  • lysosomal storage disease
  • lysosomal storage disorders
  • medicine
  • molecular Trojan horse
  • monocarboxylate transporters (MCTs)
  • Monoclonal antibody
  • mRNA transfection
  • n/a
  • nanoparticle
  • Nanoparticles
  • neurodegeneration
  • neuronopathic mucopolysaccharidosis
  • Neuroprotection
  • Neurotensin
  • neurotrophic factors
  • NSC-34 cell lines
  • organic cation transporters (OCTNs)
  • Other branches of medicine
  • parkinson’s disease
  • Parkinson’s disease (PD)
  • pharmacokinetics
  • Pharmacology
  • photo-affinity labeling
  • physiologically based PK models
  • prodrugs
  • protein-based therapy
  • Proteomics
  • proton-coupled organic cation antiporter
  • receptor-mediated transcytosis
  • receptor-mediated transcytosis (RMT)
  • receptor-mediated transport
  • single domains antibody
  • SLC transporters
  • solute carrier (SLC) transporters
  • solute carriers (SLCs)
  • ssPalm
  • SWATH-MS
  • SWATH-MS (sequential window acquisition of all theoretical-mass spectra)
  • targeting
  • taurine transporter (Taut)
  • TNF-α inhibitor
  • transferrin
  • transferrin receptor
  • transferrin receptor (TfR)
  • transferrin receptor 1 (TfR1)
  • Translation
  • trkB
  • variable new antigen receptor (VNAR)

Links

DOI: 10.3390/books978-3-0365-6416-6

Editions

edition cover

Share

Copy/paste this into your site: